本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rhythm Pharmaceuticals Inc.

99.02
+1.011.03%
盤後99.020.00000.00%19:30 EDT
成交量:61.77萬
成交額:6,150.92萬
市值:68.18億
市盈率:-31.77
高:102.00
開:101.17
低:98.80
收:98.01
52周最高:122.20
52周最低:74.50
股本:6,885.21萬
流通股本:6,539.41萬
量比:0.85
換手率:0.94%
股息:- -
股息率:- -
每股收益(TTM):-3.1172
每股收益(LYR):-3.1100
淨資產收益率:-117.04%
總資產收益率:-30.96%
市淨率:66.20
市盈率(LYR):-31.84

資料載入中...

2021/03/01

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/01

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

重要事件披露

8-K - Current report
2021/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

重要事件披露

8-K - Current report
2021/02/03

重要事件披露

8-K - Current report
2021/02/01

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/05

重要事件披露

8-K - Current report
2021/01/04

重要事件披露

8-K/A [Amend] - Current report
2020/12/11

重要事件披露

8-K - Current report
2020/11/02

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/02

重要事件披露

8-K - Current report
2020/09/16

重要事件披露

8-K - Current report